Biotech Acquisition Company (BIOTU): Price and Financial Metrics Recent IPO


Biotech Acquisition Company (BIOTU): $9.98

-0.06 (-0.60%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BIOTU Stock Price Chart Interactive Chart >

Price chart for BIOTU

BIOTU Price/Volume Stats

Current price $9.98 52-week high $10.95
Prev. close $10.03 52-week low $9.79
Day low $9.98 Volume 14,600
Day high $10.04 Avg. volume 79,253
50-day MA $10.02 Dividend yield N/A
200-day MA $0.00 Market Cap N/A

Biotech Acquisition Company (BIOTU) Company Bio


Biotech Acquisition Company operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.


BIOTU Latest News Stream


Event/Time News Detail
Loading, please wait...

BIOTU Latest Social Stream


Loading social stream, please wait...

View Full BIOTU Social Stream

Latest BIOTU News From Around the Web

Below are the latest news stories about Biotech Acquisition Co that investors may wish to consider to help them evaluate BIOTU as an investment opportunity.

Biotech Acquisition Company Announces Closing of $230,000,000 Initial Public Offering

New York, NY, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Biotech Acquisition Company (the “Company”) announced today that it has closed its initial public offering of 23,000,000 units, including 3,000,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $230,000,000. The Company’s units are listed on the Nasdaq Capital Market (“Nasdaq”) and commenced trading under the ticker symbol “BIOTU” on January 26, 2021. Each unit consists of one of the Company’s Class A ordinary shares and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. Upon sep...

Yahoo | January 28, 2021

Biotech Acquisition Company Announces Pricing of $200 Million Initial Public Offering

New York, NY, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Biotech Acquisition Company (the “Company”), a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses, today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. Although the Company may pursue a business target in any industry or geographic location, the Company intends to focus its search for a target business in the healthcare sector. The units will be listed on the Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “BIOTU” beginning January 26, 2021. Each unit consists of one Class A ordinary share and one-half of o...

Yahoo | January 26, 2021

Read More 'BIOTU' Stories Here

BIOTU Price Returns

1-mo -0.20%
3-mo -0.60%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.744 seconds.